Pfizer plans combination of off-patent drug business with Mylan

By

Pfizer plans combination of off-patent drug business with Mylan

The deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan’s shareholders owning slightly more than 40%.

Source: Business News –

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.